| CXSL2300638 | 注射用重组人凝血因子Ⅷ-Fc融合蛋白 | Recombinant Human Coagulation Factor VIII-Fc Fusion Protein | Lyophilized | Biological Products(2.4) | New Drug Application | 2023-09-21 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CXSS2300044 | 注射用重组人凝血因子Ⅷ-Fc融合蛋白 | Recombinant Human Coagulation Factor VIII-Fc Fusion Protein | Lyophilized | Biological Products(1) | New Drug Application | 2023-06-21 | | Jiangsu Shengsi Biopharmaceutical Co Ltd;Thousand Oaks Biopharmaceuticals Co Ltd | | | view |
| CXSL1700162 | 注射用重组人凝血因子Ⅷ-Fc融合蛋白 | Recombinant Human Coagulation Factor VIII-Fc Fusion Protein | Lyophilized | Biological Products(1) | New Drug Application | 2018-03-09 | 开封制药（集团）有限公司 | Kaifeng Pharmaceutical (GROUP) Co Ltd | Certificate Issued | 2018-09-25 | view |
| CXSS2101084 | 注射用重组人凝血因子Ⅷ-Fc融合蛋白 | Recombinant Human Coagulation Factor VIII-Fc Fusion Protein | Lyophilized | Biological Products(1) | New Drug Application | 2021-12-23 | | Jiangsu Shengsi Biopharmaceutical Co Ltd;Thousand Oaks Biopharmaceuticals Co Ltd | | | view |
| CXSS2300045 | 注射用重组人凝血因子Ⅷ-Fc融合蛋白 | Recombinant Human Coagulation Factor VIII-Fc Fusion Protein | Lyophilized | Biological Products(1) | New Drug Application | 2023-06-21 | | Jiangsu Shengsi Biopharmaceutical Co Ltd;Thousand Oaks Biopharmaceuticals Co Ltd | | | view |
| CXSS2101083 | 注射用重组人凝血因子Ⅷ-Fc融合蛋白 | Recombinant Human Coagulation Factor VIII-Fc Fusion Protein | Lyophilized | Biological Products(1) | New Drug Application | 2021-12-23 | | Jiangsu Shengsi Biopharmaceutical Co Ltd;Thousand Oaks Biopharmaceuticals Co Ltd | | | view |
| CXSL1700163 | 注射用重组人凝血因子Ⅷ-Fc融合蛋白 | Recombinant Human Coagulation Factor VIII-Fc Fusion Protein | Lyophilized | Biological Products(1) | New Drug Application | 2018-03-09 | 开封制药（集团）有限公司 | Kaifeng Pharmaceutical (GROUP) Co Ltd | Certificate Issued | 2018-09-25 | view |
| CXSB2400122 | 注射用重组人凝血因子Ⅷ-Fc融合蛋白 | Recombinant Human Coagulation Factor VIII-Fc Fusion Protein | Lyophilized | Biological Products(2.4) | Supplementary Application | 2024-10-13 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CXSL2300639 | 注射用重组人凝血因子Ⅷ-Fc融合蛋白 | Recombinant Human Coagulation Factor VIII-Fc Fusion Protein | Lyophilized | Biological Products(2.4) | New Drug Application | 2023-09-21 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| JYSB2000568 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2020-11-18 | | Baxter AG;Baxalta Manufacturing Sàrl | Filed | 2020-12-01 | view |
| JYSB2300036 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2023-02-23 | | Bayer Healthcare LLC | | | view |
| JYSB1800204 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-09-29 | | Wyeth Farma SA;Pfizer Ltd | Certificate Issued | 2019-06-04 | view |
| JYSB2200145 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-08-08 | | Bayer Healthcare LLC | | | view |
| JYSB2500025 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2025-02-08 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
| JYSB1800058 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-03-28 | | Baxter AG;Baxalta Manufacturing Sàrl | Filed | 2018-04-13 | view |
| CXSB2400019 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-03-09 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| JYSZ1700006 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2017-03-06 | 惠氏制药有限公司 | Wyeth Pharmaceutical Co Ltd;Wyeth Farma SA;Pfizer Ltd | Certificate Issued | 2018-07-18 | view |
| JYSB1900284 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2019-11-22 | | Baxter AG;Baxalta Manufacturing Sàrl | Certificate Issued | 2020-01-03 | view |
| JXSS1900040 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2019-07-10 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2021-01-05 | view |
| JYSZ2200049 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2022-09-14 | | Bayer Healthcare LLC;Bayer Healthcare Company Ltd | | | view |
